CDERLearn Training and Education
Learning opportunities for healthcare professionals, academia, students, and consumers
Search General Courses Search Industry Courses
Upcoming Free CE Opportunities
- September 27, 2022: FDA Drug Topics: Development and U.S. Regulation of Preventative Vaccines
- October 25, 2022: FDA Drug Topics: Understanding Generic Narrow Therapeutic Index Drugs
- November 29, 2022: FDA Drug Topics: The Safety Evaluation and Surveillance of Generic Drugs
For Industry
- September 20-21, 2022: Advancing Generic Drug Development: Translating Science to Approval
Summary | Type | Topic |
---|---|---|
The History of FDA | Health Care Professionals; Webinars | Drug Development; Drug Regulatory Process; Drug Safety |
Bench to Bedside: Integrating Sex and Gender to Improve Human Health | CE Credits; Health Care Professionals; Webinars | Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health |
Q&A with FDA | Podcasts | COVID-19 |
Biosimilars Level 1: Foundational Concepts | Health Care Professionals | Biosimilars |
Biosimilars Level 2: Regulatory and Scientific Concepts | Health Care Professionals | Biosimilars; Drug Regulatory Process |
Biosimilars Videos | Healthcare Professionals; Videos | Biosimilars; Drug Regulatory Process |
Drug Approval Case Studies | Health Care Professionals | Drug Regulatory Process |
FDA’s Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond | Health Care Professionals; CE Credits | Drug Regulatory Process |
Practitioners’ Guide for Improving Oral Anticoagulant Use | Health Care Professionals; CE Credits | Oral Anticoagulant; Disease States |
The FDA Bad Ad Program and Prescription Drug Promotion | Health Care Professionals; CE Credits | Prescription Drug Promotion |
FDA MedWatch and Patient Safety | Health Care Professionals | MedWatch; Drug Safety |
The FDA Process for Approving Generic Drugs | Health Care Professionals | Drug Regulatory Process; Drug Development; Generic Drugs |
FDA Overview of Biosimilar Products | Health Care Professionals | Biosimilars |
Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes | Health Care Professionals | Diabetes; Disease States |
Director's Corner Podcasts | Podcasts | Drug Regulatory Process; Drug Development |
Drug Information Soundcast in Clinical Oncology (D.I.S.C.O) | Health Care Professionals; Podcasts | Cancer Drugs |
FDA Drug Safety Podcasts | Health Care Professionals; Podcasts | Drug Safety |
Regulatory Science at CDER Podcasts | Podcasts | Drug Development |
FDA's Biomarker Qualification Program | Videos | Biomarker; Drug Development |
Biosimillars Patient and Prescriber Outreach Materials | Health Care Professionals; Videos | Biosimilars; Drug Regulatory Process; Drug Development |
FDA Drug Info Rounds | Health Care Professionals; Videos | Drug Safety; MedWatch; IND; Drug Development; Drug Regulatory Process; Prescription Drug Promotion; Disease States; Registration and Listing; Generic Drugs |
GDUFA II Videos and Resources | Videos | Drug Development; Generic Drugs |
Regulatory Science at CDER Videos | Videos | Drug Regulatory Process; Drug Development |
Biosimlars Online Courses, Webinars, and Presentations | Health Care Professionals; Webinars | Biosimliars; Drug Regulatory Process; Drug Development |
CDER Webinars | Health Care Professionals; Webinars | Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Registration and Listing; Electronic Submissions; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs |
Division of Drug Information Webinars | Health Care Professionals; Webinars; CE Credits | Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs |
Compounding Quality Center of Excellence On-Demand Training | Health Care Professionals; Webinars; CE Credits | Compounding; Drug Regulatory Process; Generic Drugs |
Additional Resources
- FDA Continuing Education Programs
- Training and Continuing Education
- For questions contact CDER Division of Drug Information
Sub-Topic Paragraphs
Paragraph Header
Contact Us
Paragraph Header
Contact Us
Contact Point
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
Toll Free
(855) 543-3784
(301) 796-3400
Hours Available
CDER Division of Drug Information
For Updates on Twitter follow
Contact Point Twitter
@FDA_Drug_Info
Your source for the latest drug information.
Know the moment it happens.